Yue Hao
- Pharmacology top 5%
- Molecular Biology
- Complementary and alternative medicine top 5%
- Oncology
- Pharmacology
- Topics
- Lung Cancer Treatments and Mutations (13 papers)Myasthenia Gravis and Thymoma (10 papers)Cancer Immunotherapy and Biomarkers (7 papers)
- Journals
- SHILAP Revista de lepidopterologíaClinical Cancer ResearchInternational Journal of Molecular Sciences
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Yue Hao
32 papers receiving 283 citations
Peers
Comparison fields: 5 of 51
- Pharmacology 151
- Molecular Biology 99
- Complementary and alternative medicine 70
- Oncology 51
- Pharmacology 46
Countries citing papers authored by Yue Hao
This map shows the geographic impact of Yue Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yue Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yue Hao more than expected).
Fields of papers citing papers by Yue Hao
This network shows the impact of papers produced by Yue Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yue Hao. The network helps show where Yue Hao may publish in the future.
Co-authorship network of co-authors of Yue Hao
This figure shows the co-authorship network connecting the top 25 collaborators of Yue Hao. A scholar is included among the top collaborators of Yue Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yue Hao. Yue Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 3 | |
| 5 | 2 | |
| 6 | 0 | |
| 7 | 0 | |
| 8 | 5 | |
| 9 | 9 | |
| 10 | 3 | |
| 11 | 6 | |
| 12 | 5 | |
| 13 | 4 | |
| 14 | 2 | |
| 15 | 0 | |
| 16 | 3 | |
| 17 | 0 | |
| 18 | 10 | |
| 19 | 2 | |
| 20 | 93 |
About Yue Hao
Yue Hao is a scholar working on Oncology, Neurology and Pharmacology, having authored 39 papers that have together received 285 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (13 papers), Myasthenia Gravis and Thymoma (10 papers) and Cancer Immunotherapy and Biomarkers (7 papers). The work is most often cited by research in Pharmacology (151 citations), Complementary and alternative medicine (70 citations) and Analytical Chemistry (40 citations). Yue Hao has collaborated with scholars based in China, United States and France. Frequent co-authors include Fengrui Song, Zongwei Cai, Zhi‐Quan Liu, Zifeng Pi, Zhiqiang Liu, Huilin Li, Zhengbo Song, C. Xu, Wenxian Wang and Shuying Liu. Their work appears in journals such as SHILAP Revista de lepidopterología, Clinical Cancer Research and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.